Volume | 818,984 |
|
|||||
News | - | ||||||
Day High | 0.175 | Low High |
|||||
Day Low | 0.165 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Elite Pharmaceuticals Inc (QB) | ELTP | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.165 | 0.165 | 0.175 | 0.1705 | 0.169 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
113 | 818,984 | $ 0.171557 | $ 140,502 | - | 0.0301 - 0.2119 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
15:57:52 | 2,000 | $ 0.1705 | USD |
Elite Pharmaceuticals Inc (QB) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
173.02M | 1.01B | 705.48M | 34.16M | 3.56M | 0.00 | 48.57 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Elite Pharmaceuticals (QB) News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ELTP Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.139 | 0.175 | 0.1351 | 0.1568922 | 694,155 | 0.0315 | 22.66% |
1 Month | 0.129 | 0.175 | 0.1231 | 0.1423083 | 576,603 | 0.0415 | 32.17% |
3 Months | 0.1649 | 0.175 | 0.1213 | 0.1431028 | 621,473 | 0.0056 | 3.40% |
6 Months | 0.1585 | 0.2119 | 0.1213 | 0.1610052 | 1,102,431 | 0.012 | 7.57% |
1 Year | 0.0322 | 0.2119 | 0.0301 | 0.1260134 | 1,124,382 | 0.1383 | 429.50% |
3 Years | 0.05455 | 0.2119 | 0.023 | 0.0837047 | 742,166 | 0.11595 | 212.56% |
5 Years | 0.0783 | 0.2119 | 0.023 | 0.0785137 | 836,082 | 0.0922 | 117.75% |
Elite Pharmaceuticals (QB) Description
Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma, LLC, and TAGI Pharma. Elite operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. For more information, visit www.elitepharma.com. |